Closed · RFA-DD-23-001 · CFDA 93.073 · Discretionary

Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS)

Federal grant opportunity posted by Centers for Disease Control and Prevention - ERA, cataloged on Grants.gov.

$100K-$1.2M
Award range
Closed
Status
January 17, 2023
Close date
10
Expected awards

The verdict

Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS) is a closed discretionary listing from Centers for Disease Control and Prevention - ERA that offered $100,000 -- $1,160,000 across 10 expected awards. Future funding cycles may be published under the same CFDA number.

$100K-$1.2M
award range
Closed
application status
10
expected awards
93.073
CFDA program

Opportunity snapshot. This Grants.gov announcement - Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS) - is cataloged under number RFA-DD-23-001 and tied to CFDA assistance listing 93.073, posted by Centers for Disease Control and Prevention - ERA. Grants.gov currently shows the opportunity as closed, first posted on November 1, 2022 and last updated on December 14, 2022. The funding category is Discretionary, delivered as a cooperative agreement.

Award economics. The award range on file is $100,000 -- $1,160,000. The agency has projected $20.6 million in total estimated funding for this announcement. It expects to issue 10 awards. If the agency funds the expected 10 awards from the $20.6 million estimated pool, the average award works out to roughly $2.1 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. This opportunity closed on January 17, 2023. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.

Award Range

$100,000 -- $1,160,000

Close Date

January 17, 2023

Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.

Posted

November 1, 2022

Est. Total Funding

$20,650,000

Expected Awards

10

Instrument

Cooperative Agreement

Description

Birth defects affect about three percent of all births in the United States and are a leading cause of infant mortality, morbidity, and healthcare costs. Birth defects account for one in five infant deaths and contribute substantially to long-term disability. Although some causes of birth defects have been identified (e.g., genetics, medications, and environmental exposures), the causes of two-thirds of birth defects remain unknown. In 1996 Congress appropriated funds to develop the Centers for Birth Defects Research and Prevention (CBDRP). Beginning that fiscal year, CDC awarded cooperative agreements to up to 9 different centers. The two major collaborative activities of the centers have been case-control studies called the National Birth Defects Prevention Study (NBDPS), which collected data for deliveries between 1997 and 2011, and the Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS), which began collecting data for deliveries in 2014 and is ongoing through 2023. To support research assessing risk factors for stillbirths (fetal deaths at 20 or more weeks gestation), a largely understudied pregnancy outcome, a case-control study of risk factors for stillbirth was added to BD-STEPS in 2015. This notice of funding opportunity will continue to support the capacity of BD-STEPS to identify novel epidemiologic and genetic risk factors for major, structural birth defects and for stillbirths, and to provide research findings that are intended to be translated into public health prevention messages, as warranted. Component A (BD-STEPS Core): Support the epidemiological and genetic birth defect-related research capabilities of BD-STEPS, with a focus on studying: (1) maternal chronic diseases and their treatments; (2) infectious disease in pregnancy; and (3) medications used during pregnancy. Component B (BD-STEPS Stillbirth): Support the exploration of modifiable risk factors for stillbirths. Component B recipients must apply for and receive concurrent Component A funding. New applicants and current BD-STEPS recipients are encouraged to apply for both components.

Eligibility

Grants.gov lists this opportunity under eligibility category codes 00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 25, 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Alison Amoroso uxl8@cdc.gov

Key Dates

Posted November 1, 2022
Close Date January 17, 2023
Archive Date February 9, 2023
Last Updated December 14, 2022

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS)", offered by Centers for Disease Control and Prevention - ERA. It is associated with CFDA program 93.073. Birth defects affect about three percent of all births in the United States and are a leading cause of infant mortality, morbidity, and healthcare costs. Birth defects account for one in five infant d...
Is this opportunity still open?
No, this opportunity is closed. It closed on January 17, 2023. Check the parent program page for future funding cycles.
How much funding is available?
The award range for this opportunity is $100,000 -- $1,160,000. Total estimated funding: $20,650,000. Expected number of awards: 10.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants